← All insights▼
▼
Sponsor Alignment· Sponsor ↔ sector
Angie Craig (D) is primary sponsor of Pharmaceuticals & Biotech bill hr6833-117; Pharmaceuticals & Biotech is a top donor industry (2%)
The bill hr6833-117 would cap insulin cost-sharing at $35 monthly under private insurance and Medicare, directly regulating the Pharmaceuticals & Biotech industry. Rep. Angie Craig (D-MN) introduced this bill. Pharmaceuticals & Biotech comprises 2.3% of Craig's identifiable donor base ($0.39M), ranking 53rd among donor industries within her party.
💊
Pharmaceuticals & Biotech
top donor sector
gave $391K
2% of their funding
▶
Angie Craig
D-MN · House
sponsored
industry: pharma
▶
📜
HR6833-117
their bill
2%
of their classified donations are from this sector
$391K
from Pharmaceuticals & Biotech
#53
most-funded by this sector in their party (of 251)
FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated June 26, 2026 · internal signal score 45/100.